Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'SOCIE G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 152 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Garderet, L; Bittencourt, H; Kaliski, A; Daniel, MT; Ribaud, P; Socie, G; Gluckman, E
      Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    2. Michallet, M; Bilger, K; Garban, F; Attal, M; Huyn, A; Blaise, D; Milpied, N; Moreau, P; Bordigoni, P; Kuentz, M; Sadoun, A; Cahn, JY; Socie, G; Thomas, X; Arnaud, P; Raus, N; Lheritier, V; Pigneux, A; Boiron, JM
      Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome

      JOURNAL OF CLINICAL ONCOLOGY
    3. Rocha, V; Carmagnat, MV; Chevret, S; Flinois, O; Bittencourt, H; Esperou, H; Garnier, F; Ribaud, P; Devergie, A; Socie, G; Dal'Cortivo, L; Marolleau, JP; Charron, D; Gluckman, E; Rabian, C
      Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants

      EXPERIMENTAL HEMATOLOGY
    4. Morariu-Zamfir, R; Rocha, V; Devergie, A; Socie, G; Ribaud, P; Esperou, H; Parquet, N; Guardiola, P; Dal Cortivo, L; Bittencourt, H; Garnier, F; Traineau, R; Marolleau, JP; Chevret, S; Gluckman, E
      Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

      BONE MARROW TRANSPLANTATION
    5. Salooja, N; Szydlo, RM; Socie, G; Rio, B; Chatterjee, R; Ljungman, P; Van Lint, MT; Powles, R; Jackson, G; Hinterberger-Fischer, M; Kolb, HJ; Apperley, JF
      Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

      LANCET
    6. Socie, G; Loiseau, P; Tamouza, R; Janin, A; Busson, M; Gluckman, E; Charron, D
      Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

      TRANSPLANTATION
    7. Daneshpouy, M; Socie, G; Clavel, C; Devergie, A; Rivet, J; Cartier, I; Brousse, N; Birembaut, P; Gluckman, E; Janin, A
      Human papillomavirus infection and anogenital condyloma in bone marrow transplant recipients

      TRANSPLANTATION
    8. Socie, G; Mary, JY; Esperou, H; Robert, DV; Aractingi, S; Ribaud, P; Devergie, A; Toubert, ME; Boudou, P; Cathelinau, B; Gluckman, E; Vexiau, P
      Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    9. Socie, G; Clift, RA; Blaise, D; Devergie, A; Ringden, O; Martin, PJ; Remberger, M; Deeg, HJ; Ruutu, T; Michallet, M; Sullivan, KM; Chevret, S
      Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

      BLOOD
    10. Chen, Y; Scieux, C; Garrait, V; Socie, G; Rocha, V; Molina, JM; Thouvenot, D; Morfin, F; Hocqueloux, L; Garderet, L; Esperou, H; Selimi, F; Devergie, A; Leleu, G; Aymard, M; Morinet, F; Gluckman, E; Ribaud, P
      Resistant herpes simplex virus type 1 infection: An emerging concern afterallogeneic stem cell transplantation

      CLINICAL INFECTIOUS DISEASES
    11. Girinsky, T; Benhamou, E; Bourhis, JH; Dhermain, F; Guillot-Valls, D; Ganansia, V; Luboinski, M; Perez, A; Cosset, JM; Socie, G; Baume, D; Bouaouina, N; Briot, E; Beaudre, A; Bridier, A; Pico, JL
      Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    12. Morschhauser, F; Cayuela, JM; Martini, S; Baruchel, A; Rousselot, P; Socie, G; Berthou, P; Jouet, JP; Straetmans, N; Sigaux, F; Fenaux, P; Preudhomme, C
      Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients

      JOURNAL OF CLINICAL ONCOLOGY
    13. Guermazi, A; Nguyen, S; Quoc, SN; Socie, G; Briere, J; de Kerviler, E; Solal-Celigny, P; Frija, J; Rousselot, P
      Myeloblastoma (chloroma) in leukemia - Case 1. Granulocytic sarcoma (chloroma) of the breast

      JOURNAL OF CLINICAL ONCOLOGY
    14. Davies, SM; Ramsay, NKC; Klein, JP; Weisdorf, DJ; Bolwell, B; Cahn, JY; Camitta, BM; Gale, RP; Giralt, S; Heilmann, C; Henslee-Downey, PJ; Herzig, RH; Hutchinson, R; Keating, A; Lazarus, HM; Milone, GA; Neudorf, S; Perez, WS; Powles, RL; Prentice, HG; Schiller, G; Socie, G; Vowels, M; Wiley, J; Yeager, A; Horowitz, MM
      Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    15. Socie, G; Curtis, RE; Deeg, HJ; Sobocinski, KA; Filipovich, AH; Travis, LB; Sullivan, KM; Rowlings, PA; Kingma, DW; Banks, PM; Travis, WD; Witherspoon, RP; Sanders, J; Jaffe, ES; Horowitz, MM
      New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    16. Yakoub-Agha, I; Damaj, G; Garderet, L; Bonnet, J; Devergie, A; Esperou, H; Ribaud, P; Socie, G; Gluckman, E
      Severe oesophagitis after allogeneic bone marrow transplantation for Fanconi's anemia

      BONE MARROW TRANSPLANTATION
    17. Michallet, M; Thomas, X; Vernant, JP; Kuentz, M; Socie, G; Esperou-Bourdeau, H; Milpied, N; Blaise, D; Rio, B; Reiffers, J; Jouet, JP; Cahn, JY; Bourhis, JH; Lioure, B; Leporrier, M; Sotto, JJ; Souillet, G; Sutton, L; Bordigoni, P; Dreyfus, F; Tilly, H; Gratecos, N; Attal, M; Leprise, PY; Demeocq, F; Michel, G; Buzyn, A; Delmas-Marsalet, B; Bernaudin, F; Ifrah, N; Sadoun, A; Guyotat, D; Cavazzana-Cavo, M; Caillot, D; De Revel, T; Vannier, JP; Baruchel, A; Fegueux, N; Tanguy, ML; Thiebaut, A; Belhabri, A; Archimbaud, E
      Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)

      BONE MARROW TRANSPLANTATION
    18. Parquet, N; Reigneau, O; Humbert, H; Guignard, M; Ribaud, P; Socie, G; Devergie, A; Esperou, H; Gluckman, E
      New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    19. Bellucci, S; Damaj, G; Boval, B; Rocha, V; Devergie, A; Agha, IY; Garderet, L; Ribaud, P; Traineau, R; Socie, G; Gluckman, E
      Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization

      BONE MARROW TRANSPLANTATION
    20. Socie, G
      Is syndrome "X" another late complication of bone-marrow transplantation?

      LANCET
    21. Bacigalupo, A; Brand, R; Oneto, R; Bruno, B; Socie, G; Passweg, J; Locasciulli, A; Van Lint, MT; Tichelli, A; McCann, S; Marsh, J; Ljungman, P; Hows, J; Marin, P; Schrezenmeier, H
      Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - The European Group for Blood and Marrow Transplantation Experience

      SEMINARS IN HEMATOLOGY
    22. Socie, G; Rosenfeld, S; Frickhofen, N; Gluckman, E; Tichelli, A
      Late clonal diseases of treated aplastic anemia

      SEMINARS IN HEMATOLOGY
    23. Guardiola, P; Kuentz, M; Garban, F; Blaise, D; Reiffers, J; Attal, M; Buzyn, A; Lioure, B; Bordigoni, P; Fegueux, N; Tanguy, ML; Vernant, JP; Gluckman, E; Socie, G
      Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Michallet, M; Tanguy, ML; Socie, G; Thiebaut, A; Belhabri, A; Milpied, N; Reiffers, J; Kuentz, M; Cahn, JY; Blaise, D; Demeocq, F; Jouet, JP; Michallet, AS; Ifrah, N; Vilmer, E; Molina, L; Michel, G; Lioure, B; Cavazzana-Calvo, M; Pico, JL; Sadoun, A; Guyotat, D; Attal, M; Cure, H; Bordigoni, P; Sutton, L; Buzyn-Veil, A; Tilly, M; Leporrier, M; Fegueux, N; Dreyfus, F; Rio, B; Lutz, P; Vernant, JP
      Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Bacigalupo, A; Oneto, R; Bruno, B; Socie, G; Passweg, J; Locasciulli, A; Van Lint, MT; Tichelli, A; McCann, S; Marsh, J; Ljungman, P; Hows, J; Marin, P; Schrezenmeier, H
      Current results of bone marrow transplantation in patients with acquired severe aplastic anemia - Report of the European group for blood and marrow transplantation

      ACTA HAEMATOLOGICA
    26. Socie, G; Gluckman, E
      Cure from severe aplastic anemia in vivo and late effects

      ACTA HAEMATOLOGICA
    27. Ribaud, P; Chastang, C; Latge, JP; Baffroy-Lafitte, L; Parquet, N; Devergie, A; Esperou, H; Selimi, F; Rocha, V; Derouin, F; Socie, G; Gluckman, E
      Survival and prognostic factors of invasive aspergillosis after allogeneicbone marrow transplantation

      CLINICAL INFECTIOUS DISEASES
    28. Rowlings, PA; Curtis, RE; Passweg, JR; Deeg, HJ; Socie, G; Travis, LB; Kingma, DW; Jaffe, ES; Sobocinski, KA; Horowitz, MM
      Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation

      JOURNAL OF CLINICAL ONCOLOGY
    29. Socie, G; Thervet, E
      New immunosuppressive treatments.

      PATHOLOGIE BIOLOGIE
    30. Andersen, PK; Horowitz, MM; Klein, JP; Socie, G; Stone, JV; Zhang, MJ
      Modelling covariate adjusted mortality relative to a standard population

      STATISTICS IN MEDICINE
    31. Cohen, A; Duell, T; Socie, G; van Lint, MT; Weiss, M; Tichelli, A; Rovelli, A; Apperley, JF; Ljungman, P; Kolb, HJ
      Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data

      BONE MARROW TRANSPLANTATION
    32. McCann, S; Apperley, J; Cohen, A; Kolb, HJ; Socie, G
      Late effects of transplantation

      LANCET
    33. Socie, G; Klein, JP; Horowitz, MM
      Long-term survival after bone marrow transplantation - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    34. Socie, G; Stone, JV; Wingard, JR; Weisdorf, D; Henslee-Downey, PJ; Bredeson, C; Cahn, JY; Passweg, JR; Rowlings, PA; Schouten, HC; Kolb, HJ; Klein, JP
      Long-term survival and late deaths after allogeneic bone marrow transplantation

      NEW ENGLAND JOURNAL OF MEDICINE
    35. Bemba, M; Guardiola, P; Garderet, L; Devergie, A; Ribaud, P; Esperou, H; Noguera, MH; Gluckman, E; Socie, G
      Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria

      BRITISH JOURNAL OF HAEMATOLOGY
    36. Curtis, RE; Travis, LB; Rowlings, PA; Socie, G; Kingma, DW; Banks, PM; Jaffe, WS; Sale, GE; Horowitz, MM; Witherspoon, RP; Shriner, DA; Weisdorf, DJ; Kolb, HJ; Sullivan, KM; Sobcinski, KA; Gale, RP; Hoover, RN; Fraumeni, JF; Deeg, HJ
      Risk of lymphoproliferative disorders after bone marrow transplantation: Amulti-institutional study

      BLOOD
    37. Marsh, J; Screzenmeier, H; Marin, P; Ilhan, O; McCann, S; Socie, G; Tichelli, A; Passweg, J; Hows, J; Raghavachar, A; Locascuilli, A; Bacigalupo, A
      Treatment results in aplastic anemia trials need to be analyzed separatelyfor pediatric and adult populations - Response

      BLOOD
    38. Marsh, J; Schrezenmeier, H; Marin, P; Ilhan, O; Ljungman, P; McCann, S; Socie, G; Tichelli, A; Passweg, J; Hows, J; Raghavachar, A; Locasciulli, A; Bacigalupo, A
      Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: A report from the European bloodand marrow transplant (EBMT) severe aplastic anaemia working party

      BLOOD
    39. Cohen, A; Rovelli, A; Bakker, B; Uderzo, C; van Lint, MT; Esperou, H; Gaiero, A; Leiper, AD; Dopfer, R; Cahn, JY; Merlo, F; Kolb, HJ; Socie, G
      Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: A study by the working party for late effects-EBMT

      BLOOD
    40. Hugel, B; Socie, G; Vu, T; Toti, F; Gluckman, E; Freyssinet, JM; Scrobohaci, ML
      Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia

      BLOOD
    41. Tichelli, A; Henry-Amar, M; Socie, G
      Late clonal complications in older patients receiving immunosuppressive therapy for aplastic anemia - In response

      ANNALS OF INTERNAL MEDICINE
    42. Kolb, HJ; Socie, G; Duell, T; Van Lint, MT; Tichelli, A; Apperley, JF; Nekolla, E; Ljungman, P; Jacobsen, N; van Weel, M; Wick, R; Weiss, M; Prentice, HG
      Malignant neoplasms in long-term survivors of bone marrow transplantation

      ANNALS OF INTERNAL MEDICINE
    43. Tichelli, A; Socie, G; Henry-Amar, M; Marsh, J; Passweg, J; Schrezenmeier, H; McCann, S; Hows, J; Ljungman, P; Marin, P; Raghavachar, A; Locasciulli, A; Gratwohl, A; Bacigalupo, A
      Effectiveness of immunosuppressive therapy in older patients with aplasticanemia

      ANNALS OF INTERNAL MEDICINE
    44. Socie, G; Gluckman, E
      Allogeneic hematopoietic stem cell transplantation: current issues and future prospects.

      ANNALES DE MEDECINE INTERNE
    45. SOCIE G; CAYUELA JM; RAYNAL B; ESPEROU H; FUND X; RAFFOUX C; DEVERGIE A; RIBAUD P; MAROLLEAU JP; PARQUET N; SIGAUX F; BRISON O; GLUCKMAN E
      INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC UNRELATED DONOR TRANSPLANTATION

      Leukemia
    46. MEIGNIN V; GLUCKMAN E; GAMBARAELLI D; DEVERGIE A; RAMEE MP; JANIN A; SOCIE G
      MENINGIOMA IN LONG-TERM SURVIVORS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    47. GUARDIOLA P; SOCIE G; PASQUINI R; DOKAL I; ORTEGA JJ; VANWEELSIPMAN M; MARSH J; LOCATELLI F; SOUILLET G; CAHN JY; LJUNGMAN P; MINIERO R; SHAW J; VERMYLEN C; ARCHIMBAUD E; BEKASSY AN; KRIVAN G; DIBARTOLOMEO P; BACIGALUPO A; GLUCKMAN E
      ALLOGENEIC STEM-CELL TRANSPLANTATION FOR FANCONI-ANEMIA

      Bone marrow transplantation
    48. SOCIE G; CAYUELA JM; RAYNAL B; ESPEROU H; RAFFOUX C; SIGAUX F; BRISON O; GLUCKMAN E
      INFLUENCE OF CD34 CELL SELECTION ON THE INCIDENCE OF MIXED CHIMERISM (MC) AND MINIMAL RESIDUAL DISEASE (MRD) AFTER ALLOGENEIC UNRELATED DONOR (UD) BMT

      Bone marrow transplantation
    49. SOCIE G; DEVERGIE A; GIRINSKI T; PIEL G; RIBAUD P; ESPEROU H; PARQUET N; BRISON O; GLUCKMAN E
      TRANSPLANTATION FOR FANCONIS-ANEMIA (FA) - LONG-TERM FOLLOW-UP OF 50 PATIENTS (PTS) TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING

      Bone marrow transplantation
    50. BACIGALUPO A; BRAND R; SOCIE G; PASSY J; LOCASCIULLI A; VANLINT MT; TICHELLI A; MCCANN S; MARSH J; LJUNDGMAN; HOWS J; MARIN P; SCHREZENMEIER H
      BONE-MARROW TRANSPLANTATION (BMT) OR IMMUNOSUPPRESSIVE THERAPY (IS) FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA (SAA) - A REPORT OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTS (EBMT) SAA WORKING PARTY

      Bone marrow transplantation
    51. DEVERGIE A; PARQUET N; GARDERET L; ESPEROU H; SOCIE G; RIBAUD P; GLUCKMAN E
      ADVANTAGES OF GENO IDENTICAL BMT WITH A NON TOXIC CONDITIONING REGIMEN AS FIRST LINE TREATMENT FOR CHRONIC MYELOID-LEUKEMIA

      Bone marrow transplantation
    52. CHEN Y; LELEU G; RIBAUD P; AZOULAY E; SOCIE G; GLUCKMAN E; SCHLEMMER B
      PREDICTIVE FACTORS OF DEATH IN BMT PATIENTS ADMITTED TO INTENSIVE-CARE UNIT

      Bone marrow transplantation
    53. TRAINEAU R; SCIEUX C; AGBALIKA F; RIBAUD P; SOCIE G; ESPEROU H; DEVERGIE A; PARQUET N; BENBUNAN M; GLUCKMAN E
      USE OF FILTERED BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS (CMV) INFECTION AFTER ALLOGENEIC MARROW TRANSPLANT

      Bone marrow transplantation
    54. COHEN A; ROVELLI A; UDERZO C; VANLINT MT; SOCIE G; GAIERO A; BAKKER B; CAHN JY; DOPFER R; ESPEROU H; LEIPER A; VOSSEN JM; KOLB HJ
      FINAL RESULTS FROM THE STUDY OF THE WORKING PARTY FOR LATE EFFECTS ONFINAL HEIGHT OF PATIENTS WHO UNDERWENT BMT DURING CHILDHOOD

      Bone marrow transplantation
    55. ATTAL M; SOCIE G; MOLINA L; JOUET JP; PICO J; KUENTZ M; BLAISE D; MILPIED N; IFRAH N; PAYEN C; TANGUY ML
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT FOLLICULAR LYMPHOMA - A CASE-MATCHED ANALYSIS WITH AUTOLOGOUS TRANSPLANTATION FROM THE FRENCH BONE-MARROW TRANSPLANT GROUP REGISTRY DATA

      Bone marrow transplantation
    56. SOCIE G; SCIEUX C; GLUCKMAN E; SOUSSI T; CLAVEL C; SAULNIER P; BIREMBAULT P; BOSQ J; MORINET F; JANIN A
      SQUAMOUS-CELL CARCINOMAS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONFOR APLASTIC-ANEMIA - FURTHER EVIDENCE OF A MULTISTEP PROCESS

      Transplantation
    57. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      Transplantation
    58. Bizot, P; Nizard, R; Socie, G; Gluckman, E; Witvoet, J; Sedel, L
      Femoral head osteonecrosis after bone marrow transplantation

      CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
    59. ROCHA V; DEVERGIE A; SOCIE G; RIBAUD P; ESPEROU H; PARQUET N; GLUCKMAN E
      UNUSUAL COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA

      British Journal of Haematology
    60. SOCIE G; DEVERGIE A; GIRINSKI T; PIEL G; RIBAUD P; ESPEROU H; PARQUET N; MAAREK O; NOGUERA MH; RICHARD P; BRISON O; GLUCKMAN E
      TRANSPLANTATION FOR FANCONI ANEMIA - LONG-TERM FOLLOW-UP OF 50 PATIENTS TRANSPLANTED FROM A SIBLING DONOR AFTER LOW-DOSE CYCLOPHOSPHAMIDE AND THORACOABDOMINAL IRRADIATION FOR CONDITIONING

      British Journal of Haematology
    61. MORSCHHAUSER F; CAYUELA JM; MARTINI S; BARUCHEL A; ROUSSELOT P; SOCIE G; JOUET JP; STRAETMANS N; MARTIAT P; FENAUX P; PREUDHOMME C
      EVALUATION OF MINIMAL RESIDUAL DISEASE USING RT-PCR IN 37 T(8,21) AMLPATIENTS

      British Journal of Haematology
    62. MEIGNIN V; DEVERGIE A; BRICE P; BRISON O; PARQUET N; RIBAUD P; COJEAN I; GAULARD P; GLUCKMAN E; SOCIE G; JANIN A
      HODGKINS-DISEASE OF DONOR ORIGIN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELOGENEOUS CHRONIC LEUKEMIA

      British Journal of Haematology
    63. YAKOUBAGHA I; RIBAUD P; DEVERGIE A; GARNIER F; DAMAJ G; ROCHA V; GARDERET L; SELIMI F; GUARDIOLA P; SOCIE G; ESPEROU H; GLUCKMAN E
      BONE-MARROW TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASIA (T-MDS) AND ACUTE-LEUKEMIA (T-AL) - EXPERIENCE OF SAINT-LOUIS-HOSPITAL (PARIS)

      British Journal of Haematology
    64. PETIT T; BRISON O; DOMMERGUES M; DUMEZ Y; SOCIE G; GLUCKMAN E
      TRANSFER OF NUCLEATED MATERNAL CELLS INTO FETAL CIRCULATION DURING THE 2ND-TRIMESTER OF PREGNANCY

      British Journal of Haematology
    65. DEEG HJ; SOCIE G
      MALIGNANCIES AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION - MANY QUESTIONS, SOME ANSWERS

      Blood
    66. SOCIE G
      RECENT ADVANCES IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - FROM THE BIOLOGY TO THE CLINIC

      HEMATOLOGY AND CELL THERAPY
    67. CLAVE E; CAROSELLA ED; GLUCKMAN E; SOCIE G
      RADIATION-ENHANCED EXPRESSION OF INTERFERON-INDUCIBLE GENES IN THE KG1A PRIMITIVE HEMATOPOIETIC-CELL LINE

      Leukemia
    68. MICHEL G; SOCIE G; GEBHARD F; BERNAUDIN F; THURET I; VANNIER JP; DEMEOCQ F; LEVERGER G; PICO JL; RUBIE H; MECHINAUD F; REIFFERS J; GRATECOS N; TROUSSARD X; JOUET JP; SIMONIN G; GLUCKMAN E; MARANINCHI D
      LATE EFFECTS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA IN FIRST COMPLETE REMISSION - THE IMPACT OF CONDITIONING REGIMEN WITHOUT TOTAL-BODY IRRADIATION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE

      Journal of clinical oncology
    69. SOCIE G; STONE J; KLEIN J; SOBOCINSKI K; GLUCKMAN E; HOROWITZ MM
      ANALYSIS OF LATE CAUSES OF DEATH AMONG LONG-TERM SURVIVORS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    70. PASSWEG JR; SCHREZENMEIER H; CAMITTA B; SOCIE G; HOWS J; ROWLINGS PA; HOROWITZ MM
      ALTERNATIVE DONOR BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA

      Experimental hematology
    71. CURTIS RE; ROWLINGS PA; DEEG HJ; SHRINER DA; SOCIE G; TRAVIS LB; HOROWITZ MM; WITHERSPOON RP; HOOVER RN; SOBOCINSKI KA; FRAUMENI JF; BOICE JD
      SOLID CANCERS AFTER BONE-MARROW TRANSPLANTATION

      The New England journal of medicine
    72. TOURNILHAC O; KILADJIAN JJ; CAYUELA JM; NOGUERA ME; ZINI JM; DANIEL MT; MAAREK O; GLUCKMAN E; SOCIE G; SIGAUX F
      APLASTIC-ANEMIA IN A CASE OF HEREDITARY NEUTROPHIL FC-GAMMA RECEPTOR IIIB DEFICIENCY

      British Journal of Haematology
    73. PETIT T; DOMMERGUES M; SOCIE G; DUMEZ Y; GLUCKMAN E; BRISON O
      DETECTION OF MATERNAL CELLS IN HUMAN FETAL BLOOD DURING THE 3RD-TRIMESTER OF PREGNANCY USING ALLELE-SPECIFIC PCR AMPLIFICATION

      British Journal of Haematology
    74. TOUBERT ME; SOCIE G; GLUCKMAN E; ARACTINGI S; ESPEROU H; DEVERGIE A; RIBAUD P; PARQUET N; SCHLAGETER MH; BERESSI JP; RAIN JD; VEXIAU P
      SHORT-TERM AND LONG-TERM FOLLOW-UP OF THYROID-DYSFUNCTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITHOUT THE USE OF PREPARATIVE TOTAL-BODY IRRADIATION

      British Journal of Haematology
    75. ROWLINGS PA; PRZEPIORKA D; KLEIN JP; GALE RP; PASSWEG JR; HENSLEEDOWNEY PJ; CAHN JY; CALDERWOOD S; GRATWOHL A; SOCIE G; ABECASIS MM; SOBOCINSKI KA; ZHANG MJ; HOROWITZ MM
      IBMTR SEVERITY INDEX FOR GRADING ACUTE GRAFT-VERSUS-HOST DISEASE - RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

      British Journal of Haematology
    76. SOCIE G; CAHN JY; CARMELO J; VERNANT JP; JOUET JP; IFRAH N; MILPIED N; MICHALLET M; LIOURE B; PICO JL; WITZ F; MOLINA L; FISCHER A; BARDOU VJ; GLUCKMAN E; REIFFERS J
      AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)

      British Journal of Haematology
    77. PASSWEG JR; SOCIE G; HINTERBERGER W; BACIGALUPO A; BIGGS JC; CAMITTA BM; CHAMPLIN RE; GALE RP; GLUCKMAN E; GORDONSMITH EC; HOWS JM; KLEIN JP; NUGENT ML; PASQUINI R; ROWLINGS PA; SPECK B; TICHELLI A; ZHANG MJ; HOROWITZ MM; BORTIN MM
      BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA - HAS OUTCOME IMPROVED

      Blood
    78. RIBAUD P; SCIEUX C; PARQUET N; CARBONNEL E; SOCIE G; EMPEROU H; DEVERGIE A; SELIMI F; GLUCKMAN E
      PRELIMINARY-RESULTS OF CIDOFOVIR (HPMPC) FOR THE TREATMENT OF ADENOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) PATIENTS

      Blood
    79. PASSWEG JR; SCHREZENMEIER H; CAMMITTA B; SOCIE G; HOWS J; ROWLINGS PA; HOROWITZ MM
      ALTERNATIVE DONOR BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA

      Blood
    80. ESPEROU H; MAROLLEAU JP; ROCHA V; DALCORTIVO L; SEDKI M; PARQUET N; RAFFOUX C; TRAINEAU R; SOCIE G; BENBUNAN M; GLUCKMAN E
      ENRICHED CD34-MARROW CELLS WITH ISOLEX-300 (BAXTER(TM)) DEVICES REDUCE SEVERE GRAFT-VERSUS-HOST DISEASE (GVHD) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH UNRELATED DONOR (UD-BMT)( BONE)

      Blood
    81. ATTAL M; SOCIE G; MOLINA L; JOUET JP; PICO J; KUENTZ M; BLAISE D; MILPIED N; IFRAH N; PAYEN C; TANGUY ML
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT FOLLICULAR LYMPHOMA - A CASE-MATCHED ANALYSIS WITH AUTOLOGOUS TRANSPLANTATION FROM THE FRENCH BONE-MARROW TRANSPLANT GROUP REGISTRY DATA

      Blood
    82. ROWLINGS PA; CURTIS RE; KINGMA D; JAFFE ES; SOCIE G; DEEG HJ; TRAVIS L; HOROWITZ MM
      HODGKIN-DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - LONG-LATENCY AND ASSOCIATION WITH EPSTEIN-BARR-VIRUS

      Blood
    83. DUELL T; VANLINT MT; LJUNGMAN P; TICHELLI A; SOCIE G; APPERLEY JF; WEISS M; COHEN A; NEKOLLA E; KOLB HJ
      HEALTH AND FUNCTIONAL STATUS OF LONG-TERM SURVIVORS OF BONE-MARROW TRANSPLANTATION

      Annals of internal medicine
    84. PARQUET N; DEVERGIE A; SOCIE G; RIBAUD P; ESPEROU H; GLUCKMAN E
      VENOOCCLUSIVE DISEASE AFTER BONE-MARROW T RANSPLANTATION - USE OF HEPARIN FOR PREVENTION OF LIVER VENOOCCLUSIVE DISEASE

      Annales de medecine interne
    85. DECREMOUX P; GLUCKMAN E; PODGORNIAK MP; MENIER C; THIERRY D; CALVO F; SOCIE G
      DECREASED IL-1-BETA AND TNF-ALPHA SECRETION IN LONG-TERM BONE-MARROW CULTURE SUPERNATANT FROM FANCONIS-ANEMIA PATIENTS

      European journal of haematology
    86. SOCIE G
      COULD APLASTIC-ANEMIA BE CONSIDERED A PRE-PRE-LEUKEMIC DISORDER

      European journal of haematology
    87. SOCIE G; SOHRABI KM; CAROSELLA ED; COSSET JM; HERVATIN F; DECREMOUX P; DUTRILLAUX B; SHEIBANI KM; RABIAN C; GOURMELON P; PARMENTIER C; GLUCKMAN E
      HEMATOPOIESIS RESEARCH IN APLASTIC-ANEMIA INDUCED BY ACCIDENTAL PROTRACTED RADIATION

      Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie
    88. CLAVE E; CAROSELLA ED; GLUCKMAN E; DUBRAY B; SOCIE G
      IONIZING RADIATION EFFECTS ON THE KG1A PRIMITIVE HEMATOPOIETIC-CELL LINE

      International journal of radiation oncology, biology, physics
    89. TICHELLI A; DUELL T; WEISS M; SOCIE G; LJUNGMAN P; COHEN A; VANLINT M; GRATWOHL A; KOLB HJ
      LATE-ONSET KERATOCONJUNCTIVITIS SICCA SYNDROME AFTER BONE-MARROW TRANSPLANTATION - INCIDENCE AND RISK-FACTORS

      Bone marrow transplantation
    90. SOCIE G; MARY JY; DEGRAMONT A; RIO B; LEPORRIER M; ROSE C; HEUDIER P; ROCHANT H; CAHN JY; GLUCKMAN E
      PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS

      Lancet
    91. VU T; GRISCELLIBENNACEUR A; GLUCKMAN E; SIGAUX F; CAROSELLA ED; MENIER C; SCROBOHACI ML; SOCIE G
      APLASTIC-ANEMIA AND PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A STUDY OF THE GPI-ANCHORED PROTEINS ON HUMAN PLATELETS

      British Journal of Haematology
    92. ARACTINGI S; JANIN A; DEVERGIE A; BOURGES M; SOCIE G; GLUCKMAN E
      HISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY OF DIFFUSE MELANODERMA AFTER BONE-MARROW TRANSPLANTATION

      British journal of dermatology
    93. SOCIE G; SCIEUX C; MORINET F; VEROLA O; BOSQ J; GLUCKMAN E
      HHV8 AND EBV DNA-SEQUENCES ARE RARELY RECOVERED FROM SQUAMOUS-CELL CARCINOMA (SCC) OR PREMALIGNANT DYSKERATOSIC LESIONS OCCURRING IN PATIENTS TRANSPLANTED FOR APLASTIC-ANEMIA (AA) OR FANCONI ANEMIA (FA)

      Blood
    94. SOCIE G; MARY JY; DEGRAMONT A; GLUCKMAN E
      THE APLASTIC-ANEMIA (AA)-PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SYNDROME (SD) REVISITED - A STUDY BY THE FRENCH-SOCIETY-OF-HEMATOLOGY

      Blood
    95. GLUCKMAN E; SOCIE G; GUIVARCH C; RABANNES F; MERESSE V; HENRYAMAR M
      THE LONG-TIME FORGOTTEN HLA IDENTICAL BONE-MARROW DONOR - RESULT OF ASURVEY ON 818 PATIENTS

      Blood
    96. SOCIE G; SOBOCINSKI K; VEUMSTONE J; HOROWITZ MM
      LONG-TERM SURVIVAL AND ANALYSIS OF LATE CAUSES OF DEATH AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    97. DEVERGIE A; GIRINSKI T; SOCIE G; GLUCKMAN E
      IMMUNOSUPPRESSIVE TREATMENT WITH 1 GY LYMPHOID IRRADIATION FOR THE TREATMENT OF SEVERE CHRONIC GRAFT-VERSUS-HOST DISEASE

      Blood
    98. CURTIS RE; DEEG HJ; SOCIE G; HOROWITZ MM
      SOLID CANCERS AFTER BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    99. DEEG HJ; SOCIE G; SCHOCH G; HENRYAMAR M; WITHERSPOON RP; DEVERGIE A; SULLIVAN KM; GLUCKMAN E; STORB R
      MALIGNANCIES AFTER MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA AND FANCONI-ANEMIA - A JOINT SEATTLE AND PARIS ANALYSIS OF RESULTS IN 700 PATIENTS

      Blood
    100. SOCIE G; BACIGALUPO A; DEVERGIE A; CAROSELLA E; GLUCKMAN E
      ACQUIRED APLASTIC-ANEMIA - OPTIMUM IMMUNOSUPPRESSIVE TREATMENT

      CLINICAL IMMUNOTHERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 01:01:13